Kısa Bağırsak Sendromunda Karaciğerde Ultrastrüktürel Değişiklikler ve Cd14 Ekspresyonu

Year 2018, Volume: 12 Issue: 2, 79 - 85, 01.08.2018

Gülnur Göllü Mine Şenyücel Nalan Akyürek İpek Gönül Aykut Özkul Haluk Gökçora Aydın Yağmurlu

Abstract

Amaç: Sıçanlarda kısa bağırsak sendromunun (KBS) total parenteral beslenmeden (TPB) bağımsız karaciğer üzerindeki ultrastrüktürel ve biyokimyasal değişiklikler ve CD14 mRNA ekspresyonu üzerindeki etkilerinin araştırılması amaçlandı.Gereç ve Yöntemler: Erkek 180-220 g ağırlığındaki (n=37) Wistar Albino sıçan sham (n=16), KBS (n=21) grubu olmak üzere rastgele iki gruba ayrıldı. Sham grubunda ileoçekal valvin 15 cm proksimalinden bağırsak ayrıldı ve tekrar anastomoz edildi. KBS grubunda ise bağırsakların %75’i çıkarıldı. Tüm hayvanlara eş besleme yapıldı. CD14 mRNA ekspresyonu semikantitatif olarak RT- PCR ile değerlendirildi. Eş zamanlı olarak karaciğer fonksiyon testleri ölçüldü ve karaciğerdeki ultrastrüktürel değişiklikler incelendi.Bulgular: Karaciğer fonksiyon testlerinde istatistiksel olarak anlamlı fark saptanmadı. Karaciğerin histolojik incelenmesinde inflamasyon, fibroz ve steatoz açısından anlamlı fark bulunmamakla beraber Kolestaz KBS grubunda daha belirgindi (p<0,05). Elektron mikroskobide belirgin ultrastrüktürel değişiklikler izlendi; microvillus kanalikül uzunluğu, luminal granüler materyal varlığı ve kanalikül uzunluğunun arttığı görüldü (p<0,05). Karaciğer CD14 mRNA ekspresyonu KBS grupta anlamlı olarak arttı (p<0,05).Ultrastrüktürel değişiklikler ile CD14 mRNA ekspresyonu arasındaki korelasyon belirgin olarak gözlendi (p<0,05).Sonuç: TPN’den bağımsız KBS modelinde kolestaz ultrastrüktürel olarak gösterildi. KBS grubunda artmış CD14 mRNA ekspresyonu, portal venöz endotoksemi nedeniyle bu değişikliklerin oluşabileceğini desteklemektedir.

Keywords

Kolestaz, Endotoksemi, Karaciğer yetmezliği, PCR, Kısa bağırsak sendromu

Ultrastructural Changes and CD14 Expression in the Liver in the Short Bowel Syndrome

Abstract

Objective: Our aim was to explore the effects of short bowel syndrome (SBS) on CD14 mRNA expression in the liver and examine ultrastructural and biochemical changes in a rat model of total parenteral nutrition (TPN) independent SBS.Material and Methods: Male Wistar Albino rats, weighing 180 to 220 g (n=37) were randomly divided into two groups as sham operated (n=16) and short bowel syndrome (n=21). Division and re-anastomosis of the bowel 15 cm proximal to the ileocecal junction was performed in sham operated animals. 75% of the small intestine was resected in the short bowel syndrome group. All animals were pair-fed. CD14 mRNA expression was evaluated semiquantitatively via RTPCR. Concomitantly, liver function test were performed and ultrastructural changes in the liver were evaluated.Results: There was no statistical significant difference regarding liver function tests. There were no significant differences for inflammation, fibrosis and steatosis on histological examination of liver. Cholestasis was more prominent in the SBS group (p<0.05). There were marked ultrastructural changes on electron microscopy. Microvilli canaliculus length, presence of luminal granular biliary material and luminal length of canaliculus were increased in the SBS group (p<0.05). CD14 expression was significantly increased in the liver in the SBS group (p<0.05). The correlation between the ultrastructural changes and CD14 mRNA expression was also prominent (p<0.05)Conclusion: Cholestasis was demonstrated ultrastructurally in this rat model of TPN independent SBS. Increased expression of CD14 mRNA in the SBS group supports that these changes might occur because of portal venous endotoxemia

Keywords

Cholestasis, Endotoxemia, Hepatic failure, PCR, Short bowel syndrome

References

• 1. Btaiche IF, Khalidi N. Parenteral nutrition-associated liver complications in children. Pharmacotherapy 2002;22:188-211.
• 2. Warner B. Short- bowel syndrome. In: Grosfeld JL, O’Neill JA Jr, Coran AG, Fonkalsrud EW (eds). Principles of Pediatric Surgery. 6 ed. Pennsylvania PA: Mosby Elsevier, 2006:1369-82.
• 3. Goulet O, Ruemmele F, Lacaille F, Colomb V. Irreversible intestinal failure. J Pediatr Gastroenterol Nutr 2004;38:250-69.
• 4. Forchielli ML, Richardson D, Folkman J, Gura K, Lo CW. Better living through chemistry, constant monitoring, and prompt interventions: 26 years on home parenteral nutrition without major complications. Nutrition 2008;24:103-7.
• 5. Stanko RT, Nathan G, Mendelow H. Development of hepatic cholestasis and fibrosis in patients with massive loss of intestine supported by prolonged parenteral nutrition. Gastroenterology 1987;92:197-202.
• 6. Sondheimer JM, Asturias E, Cadnapaphornchai M. Infection and cholestasis in neonates with intestinal resection and long -term parenteral nutrition. J Pediatr Gastroenterol Nutr 1998;27:131-7.
• 7. Meehan JJ, Georgeson KE. Prevention of liver failure in parenteral nutrition- dependent children with short bowel syndome. J Pediatr Surg 1997;32:473-5.
• 8. Fong Y, Marano MA, Barber A, He W, Moldawer LL, Bushman ED, et al. Total parenteral nurition and bowel rest modify the metabolic response to endotoxin in humans. Ann Surg 1989;210:449-56.
• 9. Trauner M, Fickert P, Stauber RE. Inflammation- induced cholestasis. J Gastroenterol Hepatol 1999;14:946-59.
• 10. Owings E, Georgeson K. Management of cholestasis in infants with very low birth weight. Semin Pediatr Surg 2000;9:96-102.
• 11. Zeuzem S. Gut- liver axis. Int J Colorectal Dis 2000;15:59-82.
• 12. Jarvelainen HA, Fang C, Ingelman- Sundberg M, Lindros KO. Effect of chronic coadministration of endotoxin and ethanol on rat liver pathology and proinflammatory and anti- inflammatory cytokines. Hepatology 1999;29:1503-10.
• 13. Hua Z, Sergi C, Nation PN, Wizzard PR, Ball RO, Pencharz PB, et al. Hepatic ultrastructure in a neonatal piglet model of intestinal failure- associated liver disease. J Electron Microsc (Tokyo) 2012;61:179-86.
• 14. Kemp R, Correia RB, Sankarankutty AK, dos Santos JS, Modena JL, Mente ED, et al. Liver disease associated with intestinal failure in small bowel syndrome. Acta Cir Bras 2006;21:67-71.
• 15. Lukkari TA, Jarvelainen HA, Oinonen T, Kettunen E, Lindros KO. Short- term ethanol exposure increases the expression of Kupffer cell CD14 receptor and lipopolysaccharide binding protein in rat liver. Alcohol & Alcoholism 1999;3:311-9.
• 16. Mogilner JG, Srugo I, Lurie M, Shaoul R, Coran AG, Shiloni E, et al. Effect of probiotics on intestinal regrowth and bacterial translocation after massive small bowel resection in a rat. J Pediatr Surg 2007;42:1365-71.
• 17. Aprahamian CJ, Chen M, Yang Y, Lorenz RG, Harmon CM. Twohit rat model of short bowel syndrome and sepsis: Independent of total parenteral nutrition, short bowel syndrome is proinflammatory and injurious to the liver. J Pediatr Surg 2007;42:992-7.
• 18. Antal- Szalmas P. Evaluation of CD14 in host defence. Eur J Clin Invest 2000;30:167-79.
• 19. Takai N, Kataoka M, Higuchi Y, Matsuura K, Yamamoto S. Primary structure of rat CD14, cytokine, an NO synhase mRNA expression in mononuclear phagocyte system cells in response to LPS. J Leukoc Biol 1997;61:736-44.
• 20. Ziegler- Heitbrock H, Ulevitch RJ. CD 14: Cell surface receptor and differentiation marker. Immunol Today 1993;14:121-5.
• 21. Bellezzo JM, Britton RS, Bacon BR, Fox ES. LPS-mediated NF-kappa beta activation in rat Kupffer cells can be induced independently of CD14. Am J Physiol 1996;270:956-61.
• 22. Lichtman SN, Wang J, Lemasters JJ. LPS receptor CD14 participates in release of TNF-alpha in RAW 264.7 and peritoneal cells but not in Kupffer cells. Am J Physiol 1998;275:39-46.
• 23. Matsuura K, Ishida T, Setoguchi M, Higuchi Y, Akizuki S, Yamamoto S. Upregulation of mouse CD14 expression in Kupffer cells by lipopolysaccharide. J Exp Med 1994;179:1671-6.
• 24. Su GL, Goyert SM, Fan MH, Aminlari A, Gong KQ, Klein RD, et al. Activation of human and mouse Kupffer cells by lipopolysaccharide is mediated by CD14. Am J Physiol Gastrointest Liver Physiol 2002;283:640-5.
• 25. Andorsky DJ, Lund DP, Lillehei CW, Jacsic T, Dicanzio J, Richardson DS, et al. Nutritional and other postoperative management of neonates with short bowel syndrome correlates with clinical outcomes. J Pediatr 2001;139:27-33.